MedPath

effects of propranolol and levetiracetam to prevent migraine attacks in children 5-15 year-old childre

Not Applicable
Recruiting
Conditions
Migraine.
Migraine
Registration Number
IRCT20090412001808N5
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age 5 to 15 years
migraine attacks
headache more than once a week
Headache causing a child's disability (PedMIDAS score more than 20)
Headache prophylaxis is required in the child

Exclusion Criteria

Underlying diseases such as asthma, liver disease, diabetes
Secondary headaches or other neurological disorders such as epilepsy
receiving medications for migraine over the past two months
History of sensitivity to propranolol and levetiracetam
history of propranolol and levetiracetam for migraine prophylaxis
renal dysfunction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Headache severity. Timepoint: The beginning of the study, the 3rd month and the 6th month. Method of measurement: Visual Analogue Scales (From a score of 1-10 that is scored by the child).;Headache duration. Timepoint: The beginning of the study, the 3rd month and the 6th month. Method of measurement: minute.
Secondary Outcome Measures
NameTimeMethod
umber of migraine attacks per month. Timepoint: The beginning of the study, the 3rd month and the 6th month. Method of measurement: Number in the questionnaire.;Side effects of medication (Dizziness, drowsiness, weight loss, anorexia, memory impairment, imbalance, skin complications). Timepoint: The 3rd month and 6th month. Method of measurement: Questionnaire.;Severity of disability due to headache. Timepoint: The beginning of the study, the 3rd month and the 6th month. Method of measurement: Questionnaire (Grade 1: Score 0-10, Grade 2: Score 11-30, Grade 3: Score 31-50 and Grade 4: Scores above 50).
© Copyright 2025. All Rights Reserved by MedPath